{"schema_version":"secwatch.filing_event.v1","accession":"0001567264-26-000007","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2026-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.474355+00:00","generated_at":"2026-05-16T02:46:44.515110+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Intensity Therapeutics to effect 1-for-25 reverse stock split on Feb 18 to meet Nasdaq bid price rule","bullets":["Reverse split at 1-for-25 effective 4:01 p.m. ET Feb 18, 2026; post-split trading begins Feb 19.","Pre-split shares ~63,346,579; post-split ~2,533,863; authorized shares unchanged.","Purpose is to regain compliance with Nasdaq's $1.00 minimum bid price requirement.","No fractional shares issued; cash payment in lieu at closing price on Feb 18, adjusted for split.","Stock symbol remains INTS; new CUSIP 45828J 202."],"urls":{"canonical":"https://secwatch.observer/filing/0001567264-26-000007","json":"https://secwatch.observer/filing/0001567264-26-000007.json","markdown":"https://secwatch.observer/filing/0001567264-26-000007.md","text":"https://secwatch.observer/filing/0001567264-26-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/0001567264-26-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/intensity-20260213.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:46:44.515110+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"824cfe5719a63592e9cf6e89e0091475a9630493","claim":"INTENSITY THERAPEUTICS, INC.: Filed amendment to certificate of incorporation to effect a 1-for-25 reverse stock split (effective 2026-02-13).","evidence_excerpt":"On February 13, 2026, Intensity Therapeutics, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-25 (the “Reverse Stock Split”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/0001567264-26-000007-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001193125-26-211978","ticker":"JPM","company_name":"JPMORGAN CHASE & CO","filed_at":"2026-05-07T23:59:59+00:00","headline":"JPMorgan issues $3B of 6.100% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series PP","event_type":"other_material","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-211978","json":"https://secwatch.observer/filing/0001193125-26-211978.json","markdown":"https://secwatch.observer/filing/0001193125-26-211978.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/19617/000119312526211978/0001193125-26-211978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/19617/000119312526211978/d903351d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On February 13, 2026, Intensity Therapeutics, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-25 (the “Reverse Stock Split”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/0001567264-26-000007-index.htm","comparable_excerpt":"On May 6, 2026, the Company filed a Certificate of Designations, Powers, Preferences and Rights with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges, qualifications, restrictions and limitations relating to the Series PP Preferred Stock","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/19617/000119312526211978/0001193125-26-211978-index.htm"}},{"accession":"0001829126-26-004744","ticker":"KALA","company_name":"KALA BIO, Inc.","filed_at":"2026-05-07T23:59:59+00:00","headline":"KALA BIO announces 1-for-50 reverse stock split effective May 8, 2026","event_type":"other_material","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-004744","json":"https://secwatch.observer/filing/0001829126-26-004744.json","markdown":"https://secwatch.observer/filing/0001829126-26-004744.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626004744/0001829126-26-004744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626004744/kalabio_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On February 13, 2026, Intensity Therapeutics, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-25 (the “Reverse Stock Split”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/0001567264-26-000007-index.htm","comparable_excerpt":"On May 7, 2026, KALA BIO, Inc. (the “ Company ”) filed a Certificate of Amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation (as amended, the “ Certificate of Incorporation ”) with the Secretary of State of Delaware to effect a 1-for-50 reverse stock split of the shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), either issued and outstanding or held by the Company as treasury stock, effective as of 4:05 p.m. (Delaware time) on May 8, 2026 (the “ Reverse Stock Split ”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626004744/0001829126-26-004744-index.htm"}},{"accession":"0001437749-26-013905","ticker":"BKYI","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2026-04-29T23:59:59+00:00","headline":"BIO-key announces 1-for-10 reverse stock split to regain Nasdaq compliance","event_type":"other_material","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-013905","json":"https://secwatch.observer/filing/0001437749-26-013905.json","markdown":"https://secwatch.observer/filing/0001437749-26-013905.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926013905/0001437749-26-013905-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926013905/bkyi20260429_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On February 13, 2026, Intensity Therapeutics, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-25 (the “Reverse Stock Split”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/0001567264-26-000007-index.htm","comparable_excerpt":"the Company filed a Certificate of Amendment (the “ Certificate of Amendment ”) with the Secretary of State of the State of Delaware to effect the reverse stock split. The Certificate of Amendment will become effective at 5:00 p.m., Eastern Time, on April 29, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926013905/0001437749-26-013905-index.htm"}},{"accession":"0001628280-26-039465","ticker":"IOT","company_name":"Samsara Inc.","filed_at":"2026-06-01T20:07:41+00:00","headline":"Samsara Inc. reincorporates from Delaware to Nevada, effective June 1, 2026","event_type":"other_material","sec_items":["3.03","5.03","9.01"],"materiality_score":0.45,"calibrated_materiality_score":0.45,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039465","json":"https://secwatch.observer/filing/0001628280-26-039465.json","markdown":"https://secwatch.observer/filing/0001628280-26-039465.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642896/000162828026039465/0001628280-26-039465-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642896/000162828026039465/iot-20260601.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On February 13, 2026, Intensity Therapeutics, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-25 (the “Reverse Stock Split”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/0001567264-26-000007-index.htm","comparable_excerpt":"the reincorporation of the Company from the State of Delaware to the State of Nevada (the “Reincorporation”) became effective on June 1, 2026, at 12:02 a.m. Pacific Time","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1642896/000162828026039465/0001628280-26-039465-index.htm"}},{"accession":"0001437749-26-018930","ticker":"CPSH","company_name":"CPS TECHNOLOGIES CORP/DE/","filed_at":"2026-06-01T13:35:50+00:00","headline":"CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share","event_type":"other_material","sec_items":["1.01","5.03","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018930","json":"https://secwatch.observer/filing/0001437749-26-018930.json","markdown":"https://secwatch.observer/filing/0001437749-26-018930.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/cpsh20260528_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On February 13, 2026, Intensity Therapeutics, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-25 (the “Reverse Stock Split”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/0001567264-26-000007-index.htm","comparable_excerpt":"On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm"}},{"accession":"0001193125-26-215756","ticker":"GIG","company_name":"GigCapital7 Corp.","filed_at":"2026-05-11T23:59:59+00:00","headline":"GigCapital7 domestication from Cayman Islands to Delaware effective May 8 after shareholder vote","event_type":"other_material","sec_items":["3.03","5.03","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-215756","json":"https://secwatch.observer/filing/0001193125-26-215756.json","markdown":"https://secwatch.observer/filing/0001193125-26-215756.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2023730/000119312526215756/0001193125-26-215756-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2023730/000119312526215756/d72988d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On February 13, 2026, Intensity Therapeutics, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-25 (the “Reverse Stock Split”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/0001567264-26-000007-index.htm","comparable_excerpt":"On May 8, 2026, GigCapital7 effectuated the Domestication by filing (i) a voluntary declaration pursuant to Section 206(3) of the Companies Act (revised) of the Acts of the Cayman Islands, (ii) a certificate of corporate domestication with the Secretary of State of the State of Delaware (the “ DE SoS ”), and (iii) an interim certificate of incorporation with the DE SoS (the “ Domesticated GigCapital7 Charter ”). Domesticated GigCapital7 also adopted bylaws (the “ Domesticated GigCapital7 Bylaws ” and together with the Domesticated GigCapital7 Charter, the “ Domesticated GigCapital7 Governing Documents ”) in connection with the Domestication.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2023730/000119312526215756/0001193125-26-215756-index.htm"}},{"accession":"0001062993-26-002388","ticker":"WAMFF","company_name":"Alaska Silver Corp.","filed_at":"2026-05-07T23:59:59+00:00","headline":"Alaska Silver simplifies capital structure, eliminates dual-class shares","event_type":"other_material","sec_items":["3.03","5.03","7.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-26-002388","json":"https://secwatch.observer/filing/0001062993-26-002388.json","markdown":"https://secwatch.observer/filing/0001062993-26-002388.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1893899/000106299326002388/0001062993-26-002388-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1893899/000106299326002388/form8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On February 13, 2026, Intensity Therapeutics, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-25 (the “Reverse Stock Split”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/0001567264-26-000007-index.htm","comparable_excerpt":"On May 6, 2026, the Board of Directors of Alaska Silver Corp. (the \"Company\"), approved an amendment (the \"Amendment\") to the Company's Articles of the Company to eliminate its dual-class share structure by (i) eliminating its proportionate voting share class and (ii) reidentifying its subordinate voting share class as the class of \"Common Shares,\" no par value, of which the Company shall be authorized to issue an unlimited number of Common Shares.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1893899/000106299326002388/0001062993-26-002388-index.htm"}},{"accession":"0001376474-26-000349","ticker":"ATVK","company_name":"Globaltek Ventures, Inc.","filed_at":"2026-05-06T23:59:59+00:00","headline":"Ameritek renamed GlobalTek; strategy shifts to batteries, robotics, aerospace, luxury housing","event_type":"other_material","sec_items":["5.03","8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001376474-26-000349","json":"https://secwatch.observer/filing/0001376474-26-000349.json","markdown":"https://secwatch.observer/filing/0001376474-26-000349.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530185/000137647426000349/0001376474-26-000349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530185/000137647426000349/atvk-20260417_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On February 13, 2026, Intensity Therapeutics, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-25 (the “Reverse Stock Split”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1567264/000156726426000007/0001567264-26-000007-index.htm","comparable_excerpt":"On April 15, 2026, GlobalTek Ventures, Inc. (formerly Ameritek Ventures, Inc.) (the “Company”) filed a Certificate of Amendment to its Articles of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Nevada (Filing Number 20265675229) to change the Company's corporate name from “Ameritek Ventures, Inc.” to “GlobalTek Ventures, Inc.”","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1530185/000137647426000349/0001376474-26-000349-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}